Bafna Pharmaceuticals Ltd

BAFNA PHARMACEUTICALS LIMITED — Trading Window closed from October 01, 2026 till 48 Hours after the declaration of Un-audited Financial Results for the Quarter ending September 30, 2026

AGM details

• Date and time: 11 Sep 2026, 10:00–10:35 IST; conducted via VC/OAVM.
• Mode: Video Conferencing / Other Audio Visual Means; record date: 04 Sep 2026; shareholders 7,093.
• No promoter attendance; attendees via VC: 6 promoters, 58 public.

Key resolutions

• Adopt audited financial statements for FY ended 31 Mar 2026 (Ordinary).
• Re-appointment of director by rotation (Ordinary).
• Ratification of remuneration of Cost Auditors for FY 2026-27 (Ordinary).

Voting results

• All resolutions passed; nearly unanimous in-favour with minimal dissent (8 votes against on two items).

Director changes

• Re-appointment of director by rotation; no new appointments or retirements disclosed.

Auditors

• Remuneration payable to Cost Auditors for FY 2026-27 ratified.

AGM details

• 31st AGM held Sept 11, 2026 at 10:00 A.M. IST via VC/OAVM.
• Remote e-voting Sept 8–10; extended 30 minutes after meeting.

Resolutions

• Adoption of audited financial statements for the financial year ended 31 March 2026 with reports.
• Re-appointment of Mr. Upendar Mekala Reddy as Director on rotation.
• Ratification of remuneration payable to Cost Auditors for FY2026-27.

Voting status

• Voting results pending; to be declared within two working days.

AGM Details

• Date: 11 September 2026
• Time: 10:00 AM IST
• Mode: VC/OAVM
• Record date: 4 September 2026
• Book closure: 5–11 September 2026
• Remote e-voting: 8–10 September 2026

Resolutions Put to Vote

• Item 1: Adoption of Audited Financial Statements for FY 2025-26
• Item 2: Re-appointment of Upendar Mekala Reddy as Director
• Item 3: Ratification of Cost Auditor remuneration for FY 2026-27 (Ordinary Resolution)
• Cost Auditor remuneration: Rs 75,000 plus taxes

Dividend

• Dividend for FY 2025-26: not declared

Director Changes

• Navin Kumar retired as Independent Director on 22 June 2026
• Upendar Mekala Reddy proposed for re-appointment

Auditor Appointments

• Statutory Auditor: Brahmayya & Co., for five years through the 32nd AGM
• Internal Auditor: M/s K S Rao & Co. for 2026-27
• Cost Auditor: M/s N Sivashankaran & Co.; remuneration Rs 75,000; ratification requested

Material Related Party Transactions

• RPTs in FY26 were in ordinary course and arm's length; none requiring shareholder approval

Other Material Approvals

• Notice confirms VC/OAVM voting, e-voting via CDSL, and quorum mechanics

AGM, book closure and e-voting details

• AGM date: 11 September 2026, 10:00 IST, via VC/OAVM.
• Book closure: 5–11 September 2026 (both days inclusive).
• Cut-off for e-voting eligibility: 4 September 2026.
• E-voting window: 8–10 September 2026.

Financial performance

• Revenue from operations: 2,658.32; Total income: 2,849.42 for quarter ended 30 Jun 2026.
• YoY: revenue declined from 3,462.40 to 2,658.32; total income from 3,521.96 to 2,849.42.
• Profit before tax: 7.51; current quarter tax nil; basic EPS: 0.03.
• Total comprehensive income: 13.59; diluted EPS: 0.03.
• Total expenses: 2,841.91; major items: material consumed 1,431.50; depreciation 178.07.
• Auditors: Limited Review; results unaudited; GST matter emphasized.

AGM & corporate actions

• Board approved unaudited results for Q1 June 30, 2026; Limited Review Report.
• 31st AGM on Sep 11, 2026 at 10:00 AM IST via VC/OAVM.
• Register of Members and share transfer books closed Sep 5–11, 2026.
• Cut-off date for voting eligibility: Sep 4, 2026.

GST matter (emphasis of matter)

• GST demand of INR 235.47 Lakhs; refunds of INR 331.09 Lakhs under stay via Madras HC writ.
• Management confident of prevailing; no adverse financial outcome; no adjustments expected.

Meeting Details

• Board to meet on Tuesday, August 11, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve Un-Audited financial results for quarter ended June 30, 2026.

Other Notes

• No other material governance or financial actions disclosed in this filing.

Dematerialisation processing status

• Dematerialisation requests for the quarter were processed and confirmed to depositories.
• Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification.
• Depository name updated as registered owner within the prescribed timeline.